CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--CardioNet, Inc. (NASDAQ:BEAT - News), a leading wireless medical technology company with an initial focus on the diagnosis and monitoring of cardiac arrhythmias, today filed a resale registration statement with the SEC related to the shares that were underlying the Mandatorily Redeemable Convertible Preferred Stock issued in March 2007. The shares being registered remain subject to lock-up agreements entered into in connection with CardioNet’s IPO, pursuant to which the holders have agreed not to sell such shares until at least September 15, 2008.
